Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefan Scholten
Observed names:
S Scholten,
S. Scholten,
Scholten, Stefan,
Stefan H-A Scholten
Institution:
Klinik Preetz
Observed institutions:
University of Bonn,
University of Cologne,
Klinik Preetz,
German Center for Infection Research,
GKV Spitzenverband,
University Hospital Carl Gustav Carus,
Technische Universität Dresden,
Praxis
show all 8
ORCID:
0000-0002-1863-8745
Observed ORCID:
0000-0002-1863-8745
OpenAlex ID:
A5078121291
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
2018
·
Yotam Bar-On
, Henning Gruell
, et al.
·
Nature Medicine
·
268
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany
2020
·
MSM Screening Study group
, Klaus Jansen
, et al.
·
BMC Infectious Diseases
·
198
PDF
Clinical characteristics of monkeypox virus infections among men with and without HIV : A large outbreak cohort in Germany
2022
·
Christian Hoffmann
, Heiko Jessen
, et al.
·
HIV Medicine
·
124
PDF
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens
2011
·
C. Wyen
, H. Hendra
, et al.
·
Journal of Antimicrobial Chemotherapy
·
109
PDF
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
2016
·
Vladimir Kartashev
, Matthias Döring
, et al.
·
Journal of Clinical Virology
·
72
PDF
Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral ( DAA )‐based hepatitis C virus ( HCV ) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
2018
·
J Bischoff
, S Mauss
, et al.
·
HIV Medicine
·
47
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
2022
·
Daniel Schmidt
, Christian Kollan
, et al.
·
Infection
·
38
PDF
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
2020
·
Christoph D Spinner
, Tim Kümmerle
, et al.
·
Open Forum Infectious Diseases
·
35
PDF
Tecovirimat for the treatment of severe Mpox in Germany
2023
·
Lennart Hermanussen
, Thomas Theo Brehm
, et al.
·
Infection
·
33
PDF
Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study
2021
·
Jean van Wyk
, Mounir Ait-Khaled
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
33
Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study
2018
·
Christoph D. Spinner
, Christoph Boesecke
, et al.
·
Infection
·
25
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men
2024
·
Laura Wagner
, Christoph Boesecke
, et al.
·
Infection
·
17
Dynamics and durability of HIV-1 neutralization are determined by viral replication
2023
·
Philipp Schommers
, Dae Sung Kim
, et al.
·
Nature Medicine
·
17
PDF
Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection
2020
·
Kathrin van Bremen
, Christian Hoffmann
, et al.
·
Liver International
·
17
PDF
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study)
2022
·
Malte B Monin
, Patrick Ingiliz
, et al.
·
Clinical Infectious Diseases
·
16
The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir
2023
·
Stefanie Sammet
, Veronique Touzeau-Römer
, et al.
·
Infection
·
15
PDF
PEPD ar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis
2016
·
G Fätkenheuer
, H Jessen
, et al.
·
HIV Medicine
·
15
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
2018
·
Julia M. Grottenthaler
, Christoph R. Werner
, et al.
·
PLoS ONE
·
14
PDF
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
2015
·
Karin Neukam
, Daniela I. Munteanu
, et al.
·
PLoS ONE
·
12
PDF
Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens
2023
·
Rachel L Batterham
, Nuria Espinosa
, et al.
·
Open Forum Infectious Diseases
·
11
PDF
Telaprevir-Containing Triple Therapy in Acute HCV Coinfection: The CHAT Study
2016
·
the CHAT study group
, Christoph Boesecke
, et al.
·
Antiviral Therapy
·
10
A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir
2004
·
S Mauss
, S Scholten
, et al.
·
HIV Medicine
·
10
Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study
2023
·
Ruolan Wang
, Mark Underwood
, et al.
·
Open Forum Infectious Diseases
·
7
PDF
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study
2020
·
Simon Weidlich
, Christoph Boesecke
, et al.
·
Journal of Antimicrobial Chemotherapy
·
7
PDF
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026
·
Amy E Colson
, Princy N Kumar
, et al.
·
The Lancet
·
6
Show more works
View as search
Works count:
56
Citation count:
1,233
H-index:
16
I10-index:
23
Year
Topic
Type
